SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
+2.74%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$611M
AUM Growth
-$2.34M
(-0.38%)
Cap. Flow
-$42.9M
Cap. Flow
% of AUM
-7.02%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
133
New
19
Increased
28
Reduced
40
Closed
21
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$24.2M |
| 2 |
Nova
NVMI
|
$10.8M |
| 3 |
Viking Therapeutics
VKTX
|
$8.42M |
| 4 |
Check Point Software Technologies
CHKP
|
$7.75M |
| 5 |
Biohaven
BHVN
|
$6.66M |
Top Sells
| 1 |
Broadcom
AVGO
|
$30.5M |
| 2 |
Kezar Life Sciences
KZR
|
$14.3M |
| 3 |
Salesforce
CRM
|
$8.64M |
| 4 |
Cytokinetics
CYTK
|
$8.44M |
| 5 |
Praxis Precision Medicines
PRAX
|
$7.54M |
Sector Composition
| 1 | Healthcare | 71.97% |
| 2 | Technology | 19.72% |
| 3 | Consumer Discretionary | 3.62% |
| 4 | Communication Services | 3.05% |
| 5 | Utilities | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
51
DELISTED
CARGO Therapeutics
CRGX
| $3.51M | 0.56% |
190,506
+35,000
| +23% | +$646K |
|
52
JFrog
FROG
$5.57B
| $3.5M | 0.56% |
120,381
+2,500
| +2% | +$72.6K |
|
53
Pliant Therapeutics
PLRX
$98.2M
| $3.33M | 0.53% |
297,362
+38,808
| +15% | +$435K |
|
54
Mineralys Therapeutics
MLYS
$2.02B
| $3.3M | 0.53% |
272,472
-170,280
| -38% | -$2.06M |
|
55
Eledon Pharmaceuticals
ELDN
$155M
| $3.23M | 0.51% |
1,297,321
+300
| +0% | +$747 |
|
56
Cullinan Oncology
CGEM
$403M
| $3.11M | 0.5% |
+185,871
| New | +$3.11M |
|
57
CrowdStrike
CRWD
$103B
| $3.05M | 0.48% |
+10,862
| New | +$3.05M |
|
58
Zura Bio
ZURA
$129M
| $3M | 0.48% |
+738,718
| New | +$3M |
|
59
NVIDIA
NVDA
$4.16T
| $2.96M | 0.47% |
24,355
+4,355
| +22% | +$529K |
|
|
60
Broadcom
AVGO
$1.43T
| $2.91M | 0.46% |
16,880
-176,720
| -91% | -$30.5M |
|
61
Camtek
CAMT
$3.57B
| $2.9M | 0.46% |
36,287
+34,347
| +1,770% | +$2.74M |
|
62
Alector
ALEC
$286M
| $2.89M | 0.46% |
620,000
+10,000
| +2% | +$46.6K |
|
63
Larimar Therapeutics
LRMR
$325M
| $2.71M | 0.43% |
414,478
+102,009
| +33% | +$668K |
|
64
Applied Therapeutics
APLT
$71.3M
| $2.65M | 0.42% |
311,572
-362,696
| -54% | -$3.08M |
|
65
Pfizer
PFE
$139B
| $2.6M | 0.41% |
90,000
| – | – |
|
66
Enlight Renewable Energy
ENLT
$3.39B
| $2.57M | 0.41% |
151,860
-17,420
| -10% | -$294K |
|
67
Ionis Pharmaceuticals
IONS
$9.44B
| $2.56M | 0.41% |
63,821
-76,417
| -54% | -$3.06M |
|
68
Global E Online
GLBE
$5.94B
| $2.47M | 0.39% |
64,384
-2,500
| -4% | -$96.1K |
|
69
VistaGen Therapeutics
VTGN
$112M
| $2.43M | 0.39% |
808,550
| – | – |
|
70
ProMIS Neurosciences
PMN
$21.9M
| $2.41M | 0.38% |
1,929,297
+115,084
| +6% | +$144K |
|
71
Savara
SVRA
$601M
| $2.39M | 0.38% |
563,107
-399,580
| -42% | -$1.69M |
|
72
ASML
ASML
$296B
| $2.37M | 0.38% |
2,840
-7,061
| -71% | -$5.88M |
|
73
Outlook Therapeutics
OTLK
$36.5M
| $2.21M | 0.35% |
413,545
-157,883
| -28% | -$843K |
|
74
Ventyx Biosciences
VTYX
$183M
| $2.21M | 0.35% |
1,012,749
| – | – |
|
75
KLA
KLAC
$115B
| $2.15M | 0.34% |
2,775
-525
| -16% | -$407K |
|